Bisoprolol Fumarate

CHEMBL1472989 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
767.0 g/mol
LogP
Phase
4

The fumarate salt of bisoprolol, used to manage hypertension, chronic heart failure, and arrhythmias such as atrial fibrillation. It improves heart function and reduces hospitalization risk in heart failure patients. Once-daily dosing supports long-term adherence.

分子量

767.0000 g/mol

TPSA

195.00 Ų

治療領域

作用機序

Highly selective beta-1 adrenergic receptor blocker reducing heart rate and myocardial contractility.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Highly selective beta-1 adrenergic receptor blocker reducing heart rate and myocardial contractility.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.O=C(O)/C=C/C(=O)O

InChI

InChI=1S/2C18H31NO4.C4H4O4/c2*1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4;5-3(6)1-2-4(7)8/h2*5-8,14-15,17,19-20H,9-13H2,1-4H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+

Molecular Formula

C40H66N2O12

HBD / HBA

6 / 14

回転可能結合数

26

重原子数

54

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

The fumarate salt of bisoprolol, used to manage hypertension, chronic heart failure, and arrhythmias such as atrial fibrillation. It improves heart function and reduces hospitalization risk in heart failure patients. Once-daily dosing supports long-term adherence.

Highly selective beta-1 adrenergic receptor blocker reducing heart rate and myocardial contractility.

Yes, Bisoprolol Fumarate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1472989. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5281064. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.